A Phase II Trial of Organoid Drug Sensitivity Testing to Guide Therapy in Unresectable Hepatocellular Carcinoma

NCT07351513 · clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
94
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Eastern Hepatobiliary Surgery Hospital